| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $116.6M | +10.2% |
| Cost of Revenue | $5.4M | +39.4% |
| R&D Expense | $13.7M | +13.9% |
| SG&A Expense | $20.8M | +29.1% |
| Operating Income | $11.5M | -28.9% |
| Pre-tax Income | $14.4M | -37.8% |
| Income Tax | $4.6M | -14.4% |
| Net Income | $9.9M | -44.8% |
| EPS (Basic) | $0.06 | -57.1% |
| EPS (Diluted) | $0.02 | -60.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.1M | +213.8% |
| Short-term Investments | $15.4M | +3.3% |
| Accounts Receivable | $31.1M | +58.7% |
| Inventory | $10.2M | +60.5% |
| Current Assets | $102.4M | +58.0% |
| Total Assets | $166.1M | +32.5% |
| Current Liabilities | $18.3M | -6.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.0M | +127.7% |
| Capital Expenditures | $1.2M | -48.6% |
| Investing Cash Flow | -$474K | +97.6% |
| Financing Cash Flow | $24.4M | +1059.8% |
| Free Cash Flow | -$180K | +97.0% |
| $23.9M |
| -11.7% |
| Stockholders' Equity | $106.0M | +67.5% |